Skip to content
10-Q

Quarterly Report

CEREBAIN BIOTECH CORP.

0001477932-19-000558

← back to feed
Filed
Feb 19, 2019 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2019 · Feb 15, 2019 63.33M sh
Operating Cash Flow Q2 2019 · Dec 31, 2018 −$191.98K
Operating Cash Flow Q2 2019 · Dec 31, 2017 −$361.95K
Cash And Equivalents Q2 2019 · Dec 31, 2018 $17.61K
Cash And Equivalents Q2 2019 · Jun 30, 2018 $64.58K
Cash And Equivalents Q2 2019 · Dec 31, 2017 $4.4K
Cash And Equivalents Q2 2019 · Jun 30, 2017 $11.35K
Stockholders Equity Q2 2019 · Dec 31, 2018 −$6.29M
Stockholders Equity Q2 2019 · Jun 30, 2018 −$5.58M
Current Liabilities Q2 2019 · Dec 31, 2018 $6.32M
Current Liabilities Q2 2019 · Jun 30, 2018 $3.1M
Total Liabilities Q2 2019 · Dec 31, 2018 $6.32M
Total Liabilities Q2 2019 · Jun 30, 2018 $5.68M
Current Assets Q2 2019 · Dec 31, 2018 $31.82K
Current Assets Q2 2019 · Jun 30, 2018 $91.6K
Total Assets Q2 2019 · Dec 31, 2018 $31.82K
Total Assets Q2 2019 · Jun 30, 2018 $91.6K
Sga Expense Q2 2019 · Dec 31, 2018 $208.48K
Sga Expense Q2 2019 · Dec 31, 2018 $402.71K
Sga Expense Q2 2019 · Dec 31, 2017 $187.54K
Sga Expense Q2 2019 · Dec 31, 2017 $476.46K
Rd Expense Q2 2019 · Dec 31, 2018 $32K
Rd Expense Q2 2019 · Dec 31, 2017 $82.31K
Rd Expense Q2 2019 · Dec 31, 2017 $124.63K
Net Income Q2 2019 · Dec 31, 2018 −$371.14K
Net Income Q2 2019 · Dec 31, 2018 −$908.44K
Net Income Q2 2019 · Dec 31, 2017 −$3.41M
Net Income Q2 2019 · Dec 31, 2017 −$3.84M